BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//International Association of Eating Disorders Professionals - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:International Association of Eating Disorders Professionals
X-ORIGINAL-URL:https://iaedpfoundation.com
X-WR-CALDESC:Events for International Association of Eating Disorders Professionals
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260508T090000
DTEND;TZID=America/New_York:20260508T150000
DTSTAMP:20260509T115637
CREATED:20260211T214943Z
LAST-MODIFIED:20260423T194208Z
UID:10001008-1778230800-1778252400@iaedpfoundation.com
SUMMARY:Milwaukee: GLP-1 Medications and Disordered Eating: A Personalized\, Evidence-Based Approach
DESCRIPTION:This event brings together two timely and thought-provoking sessions that explore the evolving intersection of nutrition\, mental health\, and medical treatment in eating disorder care. Attendees will gain a deeper understanding of emerging pharmacological approaches\, including how GLP-1 medications impact the body and their nuanced role in treating patients with complex medical and eating disorder presentations. Complementing this\, the event will examine the growing concept of Ultra-Processed Food Use Disorder (UPFUD)\, unpacking its clinical validity\, diagnostic considerations\, and relevance within today’s cultural and media landscape. Together\, these sessions offer a comprehensive\, evidence-informed perspective that equips professionals with practical insights and a more integrated framework for addressing the multifaceted challenges faced by individuals with eating disorders.
URL:https://iaedpfoundation.com/event/milwaukee-glp1/
LOCATION:Schlitz Audubon Nature Center 1111 E Brown Deer Rd Bayside\, Wisconsin  53217 United States
CATEGORIES:Chapter Event
ATTACH;FMTTYPE=image/jpeg:https://iaedpfoundation.com/wp-content/uploads/2026/02/AdobeStock_453551970-scaled-e1776973312954.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260515T080000
DTEND;TZID=America/New_York:20260515T150000
DTSTAMP:20260509T115637
CREATED:20260506T173314Z
LAST-MODIFIED:20260506T173315Z
UID:10001052-1778832000-1778857200@iaedpfoundation.com
SUMMARY:Washington State Chapter: Every Age\, Every Stage: Treating Eating Disorders Throughout the Lifespan
DESCRIPTION:The central and peripheral peptide modulation of appetite is increasingly well-known. The intersection of this science with a public that is highly desirous of weight loss has created extreme demand for an effective class of medications known as glucagon-like peptide (GLP-1) receptor agonists originally developed to assist in diabetes control. Not unexpectedly\, patients with eating disorders have a particular affinity for these medications. Many will do anything to obtain them\, whether by prescription from a medical provider or more anonymously on the internet. Yet despite early studies that have indicated that there may be physiologic risks to the individual irrespective of weight changes\, the risk versus benefit is not entirely clear. The low body weight individual with an eating disorder is likely most at risk. More recent studies have preliminarily shown some potential benefit for individuals with binge eating disorder and possibly bulimia nervosa. Further studies are needed; however\, the public and particularly those with eating disorders appear bent on trialing these medications on their own and often are already taking them at the time of admission to treatment. This presentation will review the current status of these medications\, including GLP-1 physiology\, the medical impact\, both positive and negative and a review of current medications available\, as well as their unique characteristics and FDA approval. The current literature on the physical and emotional impact and potential harm for eating disorder patients will be reviewed. The current news media coverage\, marketing campaigns and their impact on patients with eating disorders will be discussed. In addition\, this presentation will address any potential benefit from these medications in subgroups of patients with eating disorders. The goal of this presentation is to educate providers about these medications and their impact on eating disorder patients\, and to avoid the hyperbole of the contemporary media as the use of these medications continues to grow exponentially.
URL:https://iaedpfoundation.com/event/washington-state-chapter-every-age-every-stage/
LOCATION:Rainier Springs 2805 Northeast 129th Street Vancouver\, Washington  United States
CATEGORIES:Chapter Event
ATTACH;FMTTYPE=image/png:https://iaedpfoundation.com/wp-content/uploads/2026/05/Screenshot-2026-05-06-103212.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260527T120000
DTEND;TZID=America/New_York:20260527T130000
DTSTAMP:20260509T115637
CREATED:20260507T150301Z
LAST-MODIFIED:20260507T203606Z
UID:10001054-1779883200-1779886800@iaedpfoundation.com
SUMMARY:Argentina and Chile Chapter: El Ejercicio en los trastornos de la conducta alimentaria: ¿síntoma o aliado terapéutico?
DESCRIPTION:Esta masterclass aborda el rol del ejercicio en los trastornos de la conducta alimentaria (TCA) desde una perspectiva clínica y basada en evidencia\, analizando su doble dimensión como conducta saludable y potencial síntoma psicopatológico.Se revisarán los criterios que permiten diferenciar el ejercicio saludable del ejercicio compulsivo o patológico\, destacando señales de alerta conductuales\, cognitivas y fisiológicas que orientan a la presencia de un TCA.Asimismo\, se discutirán los fundamentos clínicos para la suspensión del ejercicio en contextos de riesgo médico o psiquiátrico\, así como l…Read more
URL:https://iaedpfoundation.com/event/el-ejercicio-en-los-trastornos-de-la-conducta-alimentaria-sintoma-o-aliado-terapeutico/
LOCATION:Virtual
CATEGORIES:Chapter Event,Virtual,Webinar
ATTACH;FMTTYPE=image/png:https://iaedpfoundation.com/wp-content/uploads/2026/05/Screenshot-2026-05-07-080005.png
END:VEVENT
END:VCALENDAR